Metraipolis › archive › dc_df0a6716f4d4

Saliva as an Alternative Matrix for Pharmacokinetic Research and Therapeutic Drug Monitoring of the Antituberculosis Drug Pyrazinamide — Europe PMC PMID:41750461

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41750461
DOI
10.3390/antibiotics15020163
License (as archived)
solo-consultazione
Archived
2026-11-06T04:08:44.796Z
SHA-256 of the archived text
08fe4a0947b4aec1e71faa50cce4a0e1dbf87681a3ca3ceda5df227bd6a5cc89
Stable URL of this page
https://metraipolis.com/documento/dc_df0a6716f4d4

How to cite

Saliva as an Alternative Matrix for Pharmacokinetic Research and Therapeutic Drug Monitoring of the Antituberculosis Drug Pyrazinamide — Europe PMC PMID:41750461 — Europe PMC (en), https://europepmc.org/article/MED/41750461 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_df0a6716f4d4 (Metraipolis archive dc_df0a6716f4d4, sha256 08fe4a0947b4aec1e71faa50cce4a0e1dbf87681a3ca3ceda5df227bd6a5cc89)
BibTeX
@misc{dcdf0a6716f4d4,
  title = {Saliva as an Alternative Matrix for Pharmacokinetic Research and Therapeutic Drug Monitoring of the Antituberculosis Drug Pyrazinamide — Europe PMC PMID:41750461},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41750461},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_df0a6716f4d4; sha256 08fe4a0947b4aec1e71faa50cce4a0e1dbf87681a3ca3ceda5df227bd6a5cc89},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41750461. Agents can read the archived copy with the MCP tool read_document.